What is Hoth Therapeutics Inc?
, a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; and HT-004 for treatment of asthma and allergies using inhalational administration. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 26.01M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.